Loading...
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
SARS-CoV-2-caused COVID-19 cases are growing globally, calling for developing effective therapeutics to control the current pandemic. SARS-CoV-2 and SARS-CoV recognize angiotensin-converting enzyme 2 (ACE2) receptor via the receptor-binding domain (RBD). Here, we identified six SARS-CoV RBD-specific...
Na minha lista:
| Udgivet i: | Antiviral Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219369/ https://ncbi.nlm.nih.gov/pubmed/32405117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104820 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|